Bosch Remko R, Pouwels Marie-José J M, Span Paul N, Olthaar André J, Tack Cees J, Hermus Ad R M M, Sweep C G J
Department of Chemical Endocrinology, University Medical Centre Nijmegen, The Netherlands.
Endocrine. 2004 Feb;23(1):17-24. doi: 10.1385/endo:23:1:17.
Whether the hexosamine biosynthesis pathway acts as a nutrient-sensing pathway is still unclear. Glucose is directed into this pathway by GFAT. Because the activity of GFAT is tightly regulated, we examined whether UDP-hexosamine levels can increase significantly and dose-dependently in response to elevated glucose concentrations. In glucosamine-treated 3T3-L1 adipocytes, inhibition of insulin-stimulated glucose uptake was highly correlated with UDP-hexosamine levels (r = -0.992; p < 0.0001 for UDP-GlcNAc and r = -0.996; p < 0.0001 for UDP-GalNAc). Incubation of 3T3-L1 adipocytes with 0.1 microM insulin for 24 h in medium containing 1 and 5 mM glucose increased the rate of glucose uptake by 365% and 175% compared to untreated cells, respectively. This increase was not observed when the cells were incubated for 24 h with insulin in medium containing 10 or 25 mM glucose. However, treatment of cells with insulin and 1, 5, 10, or 25 mM glucose resulted in similar increases in levels of UDP-GlcNAc and UDP-GalNAc that always amounted to approx 30-40% above baseline values. This led us to conclude that despite exposure of adipocytes to conditions of extreme and prolonged glucose disposal, the increases in cellular UDP-hexosamines were minimal and not dependent on the extracellular glucose concentration. Taken together, our results are in line with the hypothesis that in glucosamine-treated adipocytes UDP-hexosamines influence insulin-stimulated glucose uptake. However, our observations in glucose-treated adipocytes argue against the possibility that UDP-hexosamines function as a nutrient-sensor, and question the role of the hexosamine biosynthesis pathway in the pathogenesis of insulin resistance.
己糖胺生物合成途径是否作为一种营养感知途径仍不清楚。葡萄糖通过谷氨酰胺:果糖-6-磷酸酰胺转移酶(GFAT)进入该途径。由于GFAT的活性受到严格调控,我们研究了UDP-己糖胺水平是否会随着葡萄糖浓度升高而显著且呈剂量依赖性增加。在经葡糖胺处理的3T3-L1脂肪细胞中,胰岛素刺激的葡萄糖摄取抑制与UDP-己糖胺水平高度相关(UDP-GlcNAc的r = -0.992;p < 0.0001,UDP-GalNAc的r = -0.996;p < 0.0001)。在含有1 mM和5 mM葡萄糖的培养基中,将3T3-L1脂肪细胞与0.1 μM胰岛素孵育24小时,与未处理的细胞相比,葡萄糖摄取率分别提高了365%和175%。当细胞在含有10 mM或25 mM葡萄糖的培养基中与胰岛素孵育24小时时,未观察到这种增加。然而,用胰岛素和1 mM、5 mM、10 mM或25 mM葡萄糖处理细胞会导致UDP-GlcNAc和UDP-GalNAc水平出现类似的增加,总是比基线值高出约30 - 40%。这使我们得出结论,尽管脂肪细胞暴露于极端和长期的葡萄糖处理条件下,但细胞内UDP-己糖胺的增加是最小的,且不依赖于细胞外葡萄糖浓度。综上所述,我们的结果与以下假设一致:在经葡糖胺处理的脂肪细胞中,UDP-己糖胺会影响胰岛素刺激的葡萄糖摄取。然而,我们在经葡萄糖处理的脂肪细胞中的观察结果反对UDP-己糖胺作为营养传感器的可能性,并质疑己糖胺生物合成途径在胰岛素抵抗发病机制中的作用。